U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07504523) titled 'Personalized T-Cell Therapy iNeo-Vac-T01 in Advanced Colorectal Cancer' on March 22.
Brief Summary: The primary objective of this study is to evaluate the feasibility, safety, and efficacy of personalized T-cell therapy based on tumor neoantigens in patients with advanced colorectal cancer, so as to provide a novel individualized therapeutic strategy for such patients.
Study Start Date: Nov. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Metastatic Colorectal Cancer (CRC)
Intervention:
BIOLOGICAL: iNeo-Vac-T01
iNeo-Vac-T01 Injection is an individually customized tumor neoantigen-specific T cell injection. DNA and RNA sequenci...